 |
|
|
| |
Sofosbuvir, Simeprevir, +/- Ribavirin in HCV G1
Protease Inhibitor-Experienced Patients [14/15 SVR 93%]
|
| |
| |
Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
Kristen M. Marks*, Ethan M. Weinberg, Sonal Kumar, Carrie Down, Ype P. de Jong, Leah A. Burke, Mary C. Olson, Ira M. Jacobson
Weill Cornell Medical College, New York, NY New York, NY
|
| |
|
|
|
|
|
